Effectiveness of the dual serotonin norepinephrine reuptake inhibitor venlafaxine in depressed patients

Trial Profile

Effectiveness of the dual serotonin norepinephrine reuptake inhibitor venlafaxine in depressed patients

Completed
Phase of Trial: Phase II

Latest Information Update: 10 Jun 2010

At a glance

  • Drugs Atomoxetine; Paroxetine; Venlafaxine
  • Indications Major depressive disorder
  • Focus Pharmacodynamics
  • Sponsors Wyeth
  • Most Recent Events

    • 10 Jun 2010 Results preseneted at the 27th International Congress of Collegium Internationale Neuro Psychopharmacologicum
    • 05 Dec 2009 Status changed from not stated to completed.
    • 21 Aug 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top